WEKO3
アイテム
肝炎ウイルス検診の費用対効果分析 : 新潟県の検診データから考える
http://hdl.handle.net/10191/19604
http://hdl.handle.net/10191/19604c7b422e6-e8d4-4d15-964a-b33fb94f2dbf
名前 / ファイル | ライセンス | アクション |
---|---|---|
110007146300.pdf (766.4 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2012-09-28 | |||||
タイトル | ||||||
タイトル | 肝炎ウイルス検診の費用対効果分析 : 新潟県の検診データから考える | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 肝炎ウイルス検診の費用対効果分析 : 新潟県の検診データから考える | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | cost - effectiveness | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | screening | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | hepatitis C | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Markov model | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Niigata pref. | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Cost - effectiveness Analysis of the Screening for Hepatitis C in Niigata pref. | |||||
著者 |
中村, 潤一郎
× 中村, 潤一郎 |
|||||
著者別名 | ||||||
識別子 | 76953 | |||||
識別子Scheme | WEKO | |||||
姓名 | Nakamura, Junichiro | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | The aim of this study was to clarify the cost - effectiveness of the Japanese screening program for hepatitis C by analyzing the data of Niigata pref. A Markov model was constructed to demon - strate the life expectancy (LE) and the lifetime cost over 30 years. The screening was conducted dividing into two groups, one was assumed to be the general population and the other was to be the high risk group in which people had hepatic dysfunction or received blood transfusions, operations previously. In our cost - effectiveness analysis, LE and the lifetime cost including the screening cost in each group were compared between the case when people received both the screening and the anti - viral therapy (the screening case) , and the case when people received neither the screening nor the anti - viral therapy ( no screening case) . The incremental cost -effectiveness ratio of the screening case in the general population and that in the high risk group were calculated to be \1,900,166/LE gained and \2,039,653/LE gained, respectively, which were lower than the cost - effectiveness threshold of $50,000 (=\5,750,000). When we re - analyzed the cost - effectiveness by changing the parameters in our Markov model, the superiority in the cost - effectiveness of the screening case was unchanged. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 122, 号 3, p. 128-137, 発行日 2008-03 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
権利 | ||||||
権利情報 | 本文データは学協会の許諾に基づきCiNiiから複製したものである | |||||
著者版フラグ | ||||||
値 | publisher |